Drug Diversion Insights with Terri Vidals cover art

All Episodes

Drug Diversion Insights with Terri Vidals — 157 episodes

#
Title
1

Caught in the Crossfire: When Trusted Colleagues Divert

2

Your Greatest Asset: How to Make Staff Your Eyes and Ears in Diversion Prevention

3

From Deception to Recovery: Why Healthcare Needs a Culture of Self-Reporting

4

No Software? No Problem—Conducting Effective Audits

5

42 to Near Zero: A QI Approach to Anesthesia Drug Discrepancies

6

Stop the Swap: Why “Integrated Waste” Is the Gold Standard for Controlled Substances

7

Buprenorphine Deep Dive: Neuroscience, Safety, and Clinical Decision-Making

8

CS Drips: Why Every Handoff Counts in Spotting Diversion

9

Buprenorphine Unfiltered: Efficacy, Discontinuation, and Post-Acute Withdrawal

10

Med Admin Basics: A Foundation of Diversion Mitigation

11

When Careers Hang in the Balance: Interviewing Healthcare Professionals Suspected of Diversion

12

Beyond the License: What Actually Matters in Diversion Program Leadership

13

The Propofol Problem: Why This Non-Controlled Substance Still Demands Your Attention

14

Securing the Unsecured: A Mayo Clinic Study on Propofol Disposal and Diversion Mitigation

15

How Controlled Substance Waste Impacts Pharmacy Teams

16

Anticipatory Compounding: Navigating the FDA-DEA Divide in Hospital Pharmacies

17

Culture First, Compliance Second: Rethinking Drug Diversion Prevention

18

Building Better Foundations: Essential Prep Work for Effective Diversion Monitoring

19

Behind the Survey: Former Surveyors for The Joint Commission Share What They Really Look for in Diversion Prevention Programs

20

Red Flags in ADM Cancel Transactions – What Auditors Need to Know

21

Beyond Poor Practice: How to Decide When Suspicious Activity Warrants a Formal Investigation

22

Inside the OR: An Anesthesiologist's Perspective on Medication Security and Diversion Prevention

23

Milk of Amnesia: The Joint Commission Insights on Propofol Security

24

Healing Through Stories: WisPAN Launches Their Podcast to Support Nurses in Recovery

25

What Rxpert Solutions Actually Does – A Behind-the-Scenes Look at Our Services

26

How to Build a Robust Diversion Program | Real Strategies, Leadership & Innovation in Healthcare

27

Speaking Out Safely: Legal Considerations for Healthcare Professionals Sharing Recovery Stories

28

Data Without Dialogue: A Dangerous Shortcut in Diversion Investigations

29

Missing from the Table: Infection Prevention's Role in Diversion Response

30

Beyond Diversion: Understanding Medical Record Falsification in Healthcare

31

The Art of Investigative Interviewing: Insights from a Healthcare 'Unicorn'

32

Protecting Your Practice: A Compliance Expert's Guide to Corresponding Responsibility

33

New Hires Surprised by Controlled Substance Accountability

34

Industry Shakeup: Bluesight's Acquisition of Protenus and What It Means for Customers

35

A Compassionate Approach to Neonatal Abstinence Syndrome: Conversation with Tara Sundem

36

Confronting the Hidden Costs of Medication Waste in Hospital Settings

37

When Surveyors Dig Deeper: The Shift Toward Meaningful Diversion Programs

38

Healthcare Tech Evolution: Bluesight's Growth and Vision for Diversion Monitoring

39

Telemedicine Buprenorphine: Expanding Access to Opioid Use Disorder Treatment

40

Legal Preparedness in Healthcare: A Conversation with Ronald Chapman II

41

Minding Our Own Store: Pharmacy-Based Drug Diversion

42

Cross-Border Perspectives: Drug Diversion in Canadian Healthcare

43

When the Healer Needs Healing: A Doctor's Path to Recovery

44

The Sweet Connection: Linking Sugar and Drug Use Disorders

45

Optimizing Controlled Substance Waste: Research Insights from the Field

46

Christie Moon on Balancing Compliance, Employee Rights & Safety in Drug Diversion Investigations

47

Legacy of Leadership: A Conversation with IHFDA's John Burke

48

Revolutionizing Drug Testing: DNA Verification, Rapid Results, and Fentanyl Detection

49

From the Front Lines to the C-Suite: Nursing Leadership, Diversion Crises, and Battling Burnout

50

Healing the Healers: Inside South Dakota's Health Professionals Assistance Program

51

Beyond Debriefing: Exploring COMPASS and Support for Healthcare Professionals

52

Addressing Drug Diversion: A Conversation with a Compliance Expert

53

Closing the Gap in Medication Waste: How MIDAS View Adds a Critical Tool to Mitigate Drug Diversion

54

Navigating the World of Diversion Prevention: Insights from the Frontlines

55

Revolutionizing Healthcare: Wolters Kluwer's Acquisition of Invistics Flowlytics Diversion Software

56

Exploring Drug Courts with Judge Jose Salinas

57

Insights from a Psychiatric Nurse Leader on Substance Management and Ambulatory Care Challenges

58

Beyond the Error: Uncovering Impairment in Safety Events with Patches Seely

59

Dueling Detection: 3rd Party vs. In-House Automation in Diversion Monitoring

60

Collaborative Defense: Nurses & Pharmacists United Against Diversion

61

Supporting Physician Recovery with PHPs

62

Finding Balance: A Holistic Approach to Substance Use Disorder Recovery with Joseph Eisele

63

Protecting Patients, Empowering Professionals: Inside the Indiana Professional Recovery Program

64

Returning to Practice, Safeguarding Patients: South Carolina's Recovering Professionals Program

65

Personal Journey and Legal Lessons

66

Facing a Nursing License Complaint? Protect Yourself with Knowledge and Advocacy

67

Navigating the Maze: The ADA and its Implications for Healthcare Diversion Investigations

68

Beyond Nursing School: Unveiling the Truths Nurses Need to Know

69

Prescription and Prejudice: Breaking the Stigma of MAT in Healthcare

70

How Recovery Monitoring Agreements Shape Second Chances

71

Should a Healthcare Professional Self Report Diversion to their Licensing Board?

72

Tips on How to Perform a Behavioral Interview from Pharmacists with a Badge

73

A Resource All States Should Strive For

74

Is Residual Waste a Diversion Risk?

75

Let's Change the Way Healthcare Professionals Handle Repetitive Daily Stressors

76

Caduceus: A Support Group for Health Care Professionals in Recovery

77

Recovery Program for Licensed Healthcare Professionals in Massachusetts

78

What Differentiates Imprivata's Diversion Surveillance Software from the Others

79

Is Your Diversion Education Meaningful?

80

Hands On Approach to Monitoring for Diversion

81

An Overview of Drug Diversion Software from LogicStream

82

Journey to a Substance Use Disorder

83

Using Biometric Data to Improve Recovery Outcomes

84

Diversion Mitigation Starts Before an Order is Ever Written

85

Words of Wisdom From a Defense Attorney

86

Substance Use Disorders and Barriers to Treatment

87

Recovery Program for Licensed Healthcare Professionals in Michigan

88

Diversion Programs in Rural Settings

89

Possible Victim of Diversion

90

The DEA and Patient Own Meds

91

How Prepared is Your Facility for a Visit from the DEA?

92

Adjusting Interview Style to Meet the Circumstances

93

A Look Inside DEA Investigations

94

Ransomware and Controlled Substance Security

95

Recovery Program for Licensed Healthcare Professionals in California

96

When to Report to the FDA

97

History and Elimination of the DATA Waiver

98

From Manual to Automated

99

Avera Health's Successful Reintegration Program

100

Do Pediatric Hospitals Have Unique Diversion Challenges?

101

Applying the Just Culture Algorithm to Suspected Diversion

102

The Value of Peer Support Groups to Recovery

103

What Does a Healthy Recovery Program Look Like?

104

Why is Drug Diversion a Patient Safety Issue?

105

24 Years and Counting, A Success Story in the OR with Bridget Petrillo, CRNA

106

An Anesthesiologist's Perspective with Keith Berge, MD Anesthesiologist, Retired

107

Great Interview Takeaways with Denzil Lewis, Corporate Investigator for Community Health

108

UCHealth Diversion Program Triad

109

Humanizing Substance Use Disorders

110

Aaron A. Reed, DNP Founder of Focused Solutions Advocate, LLC

111

A Controlled Substance Pot Pourri Discussion

112

Different Perspective on Conducting an Interview

113

Another Tool for your Diversion Monitoring Toolkit

114

Total Well Being With the Chief Ikigai Officer of Connect3x

115

Incorporating Patient Interviews into an Investigation

116

Thoughts on Peer Group Support, Reintegration, and Interviewing

117

Waste Assaying in a Large Health System

118

Drug Testing

119

Results of a Workflow Study Time of Controlled Substance Waste

120

Jake Nichols Pharmacist in Long-term Recovery

121

CAREDirect Has an Access Control Solution for Small to Mid-size Entities

122

RxDestruct - Next Generation Pharmaceutical Waste Management

123

From Feeling Better Than Ever to Post Acute Withdrawal Syndrome

124

Benefits of a Drug Diversion Task Force

125

One Institution's Diversion Software Selection Process

126

The Drug Diversion Triad with Maureen Burger, Chief Nursing Officer at Visante

127

Cameras in the Operating Room

128

Cal Hospital Compare Opioid Care Honor Roll

129

Interview with Medacist President & CEO, David Brzozowski

130

Interview with Anigent Chief Product Officer & Managing Partner Charles D'Amato

131

How Does it Feel Knowing You May have Diversion in Your Unit - A Supervisor's Perspective

132

Joseph Buckley President of John E. Reid and Associates

133

Interview with a Scott Lamp, a Pharmacist with a Badge

134

How One Nurse's Struggles Can Work Toward Destigmatizing Substance Abuse and Help Other Healthcare Professionals on the Road to Recovery

135

First Hand Experience with Addiction and Recovery Through the Eyes of a Colleague and Loved One

136

A Conversation with Samantha Roberts, Controlled Substance Program Manager with Emory Healthcare

137

Healing Through Fasting and Healthy Eating with Dr. Alan Goldhamer

138

COVID and its Impact on Drug Addiction with Rigo Garcia

139

A Look at Pharmacolog and Their Products in the Diversion Monitoring Space

140

A Look at PharmID and Their Products in the Diversion Monitoring Space

141

Dr. Nathan Painter and the San Diego Prescription Drug Abuse Task Force

142

Rodrigo Garcia on Creating a Culture of Self Reporting

143

"Don Teater MD, MPH Pain and addiction specialist Martha Teater MA Therapist"

144

The Interview/Interrogation Process with Russ Nix

145

Interview with Nick Culbertson, CEO & Co-Founder of Protenus

146

Interview with Rodrigo Garcia, CEO of Parkdale Center

147

Simulations and Networking with Heidi McNeely

148

Interview with Tom Knight on HealthCareDiversion.org

149

Interview with Charlie Cichon, Executive Director of NADDI

150

Trauma and Predisposition to Pain and Addiction, Interview with Dr. Don and Martha Teater

151

Russ Nix on the Importance of Policies and Procedures

152

Identification & Development of a Diversion Program with Mary Nelson

153

A Story of Recovery and Hope with Dawn Reese

154

Stigma Associated with Addiction, Interview with Dr. Don and Martha Teater

155

An inside look at Flowlytics with Xing Guan

156

Interview with John Burke, Co-Founder and President of IHFDA

157

Interview with Russ Nix, Founder of Aegis RX